133 related articles for article (PubMed ID: 6702135)
21. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
22. [Pituitary hormone level in breast cancer patients].
Agranat VZ; Valiura AV; Nikogosian GA
Med Radiol (Mosk); 1981 Mar; 26(3):3-8. PubMed ID: 6783807
[No Abstract] [Full Text] [Related]
23. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Rosner B; Sluss P; Hankinson SE
Cancer Res; 2004 Sep; 64(18):6814-9. PubMed ID: 15375001
[TBL] [Abstract][Full Text] [Related]
24. [Prolactin and breast cancers].
Cappelaere P
Pathol Biol (Paris); 1975 Feb; 23(2):161-70. PubMed ID: 165449
[TBL] [Abstract][Full Text] [Related]
25. [Letter: Prolactin and breast cancer].
Rolandi E; Barreca T; Masturzo P; Polleri A; Indiveri F; Barabino A
Nouv Presse Med; 1974 Dec; 3(45):2743. PubMed ID: 4459869
[No Abstract] [Full Text] [Related]
26. [A comparative study of the level of plasma prolactin in women and men undergoing operations under halothane and neuroleptanesthesia].
Gosheva-Antonova Ts; Visheva N
Khirurgiia (Sofiia); 1991; 44(2):47-52. PubMed ID: 1895690
[TBL] [Abstract][Full Text] [Related]
27. Effects of radical mastectomy on prolactin blood levels in patients with breast cancer.
Barni S; Lissoni P; Paolorossi F; Crispino S; Rovelli F; Ferri L; Sormani A; D'Alonso U; Bugatti A; Nociti V
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1141-5. PubMed ID: 3653210
[TBL] [Abstract][Full Text] [Related]
28. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
29. Metastasis of breast cancer to a uterine leiomyoma.
Kondo NI; Yoshida S; Kajiyama H; Nagasaka T; Uematsu T
Breast Cancer; 2009; 16(2):157-61. PubMed ID: 18751874
[TBL] [Abstract][Full Text] [Related]
30. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
Tarquini B; Benvenuti M; Legnaioli M; Bazzani M; Cagnoni M; Halberg F
Cancer Detect Prev; 1981; 4(1-4):525-34. PubMed ID: 7349819
[TBL] [Abstract][Full Text] [Related]
31. Follow-up of prolactin levels in patients with breast cancer metastases treated by cryohypophysectomy.
Rozsíval V; Petr R; Fingerová H; Talas M; Janousková M; Kubícek J; Hájek P
Acta Univ Palacki Olomuc Fac Med; 1981; 101():180-4. PubMed ID: 6242689
[No Abstract] [Full Text] [Related]
32. Surgical treatment of early breast cancer in day surgery.
Marrazzo A; Taormina P; David M; Riili I; Lo Gerfo D; Casà L; Noto A; Mercadante S
Chir Ital; 2007; 59(5):687-91. PubMed ID: 18019641
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of plasma prolactin in breast cancer: comparison with the expression of c erb B-2 oncoprotein.
Bhatavdekar JM; Patel DD; Sherbet GV; Giri DD; Karelia NH; Vora HH; Shah NG; Suthar TP; Nadkarni SP; Balar DB
Eur J Surg Oncol; 1993 Oct; 19(5):409-13. PubMed ID: 8104829
[TBL] [Abstract][Full Text] [Related]
34. Prolactin and certain obstetric stress conditions.
Volpe A; Mazza V; Di Renzo GC
Int J Biol Res Pregnancy; 1982; 3(4):161-6. PubMed ID: 6818162
[TBL] [Abstract][Full Text] [Related]
35. [Cancer of the large intestine, breast and corpus uteri in the same patient].
Kushelev AE
Khirurgiia (Mosk); 1973 Mar; 49(3):116-7. PubMed ID: 4754913
[No Abstract] [Full Text] [Related]
36. [Mastopathy and endometrial hyperplasia--coexistence, relationships].
Teter J; Szamborski J
Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):188-90. PubMed ID: 8084821
[TBL] [Abstract][Full Text] [Related]
37. Hysterectomy for obese women with endometrial cancer: laparoscopy or laparotomy?
Eltabbakh GH; Shamonki MI; Moody JM; Garafano LL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):329-35. PubMed ID: 10985889
[TBL] [Abstract][Full Text] [Related]
38. [Determination of blood prolactin levels in breast diseases using prolactin radioimmunoassay kits (CIS-Prolak Kit)].
Nakajima K; Saito K; Tobioka M; Ishihara K; Kobayashi T
Horumon To Rinsho; 1976 Dec; 24(12):1303-10. PubMed ID: 1035518
[No Abstract] [Full Text] [Related]
39. [Blood prolactin levels and functional status of the sympatho-adrenal system during complex treatment of breast cancer].
Sidorenko LN; Korovin KF; Popova SP; Egor'kova AS; Shpanskaia LS
Vestn Khir Im I I Grek; 1982 Aug; 129(8):13-5. PubMed ID: 7135749
[No Abstract] [Full Text] [Related]
40. Correlates of between-surgeon variation in breast cancer treatments.
Hawley ST; Hofer TP; Janz NK; Fagerlin A; Schwartz K; Liu L; Deapen D; Morrow M; Katz SJ
Med Care; 2006 Jul; 44(7):609-16. PubMed ID: 16799355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
